Clare Khan

Direktor/Vorstandsmitglied bei SOLID BIOSCIENCES INC.

Vermögen: 9 086 $ am 31.05.2024

72 Jahre

Health Technology

Consumer Services

Aktive Positionen von Clare Khan

Unternehmen	Position	Beginn	Ende
SOLID BIOSCIENCES INC.	Direktor/Vorstandsmitglied	02.03.2021	-
SOLID BIOSCIENCES INC.	Independent Dir/Board Member	02.03.2021	-
X-Vax Technology, Inc. X-Vax Technology, Inc. BiotechnologyHealth Technology X-Vax Technology, Inc. operates as a biotechnology company. The company was founded in 2015 and is headquartered in New York, NY.	Technik-/Wissenschafts-/F&E-Leiter	01.10.2019	-
	Corporate Officer/Principal	01.10.2018	01.10.2019
Clare Kahn Pharma Consulting LLC	Präsident	01.06.2016	-

Unternehmen	Position	Beginn	Ende
PFIZER, INC.	Corporate Officer/Principal	01.06.2010	01.06.2016
GSK PLC	General Counsel	01.01.1999	01.01.2010
University of Pennsylvania	Corporate Officer/Principal	01.01.1981	01.01.1985

Royal Postgraduate Medical School

Doctorate Degree

International

Operativ

Corporate Officer/Principal	3
Director/Board Member	1
Independent Dir/Board Member	1

Sektoral

Health Technology	5
Consumer Services	3

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Börsennotierte Unternehmen	3
SOLID BIOSCIENCES INC.	Health Technology
PFIZER, INC.	Health Technology
GSK PLC	Health Technology

Private Unternehmen	2
X-Vax Technology, Inc. X-Vax Technology, Inc. BiotechnologyHealth Technology X-Vax Technology, Inc. operates as a biotechnology company. The company was founded in 2015 and is headquartered in New York, NY.	Health Technology
Clare Kahn Pharma Consulting LLC